People · Operator

GREGORY J. IKONEN

Named in public records as an officer, director or promoter · active 2011–2011 · Other Technology

1
Companies
1
Filings
$20.2M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Mendel Biotechnology IncOther TechnologySeries A$20.2M$328.6M2011
Operator network

GREGORY J. IKONEN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Justin Adams · 4 companies · 1 sharedJustin AdamsMark Lampert · 3 companies · 1 sharedMark LampertNeal Gutterson · 3 companies · 1 sharedNeal GuttersonPeter Davis · 3 companies · 1 sharedPeter DavisSteve Padgette · 2 companies · 1 sharedSteve PadgetteBRIAN J. STASKAWICZ · 1 companies · 1 sharedBRIAN J. STASKAWI…Brian Staskawicz · 1 companies · 1 sharedBrian StaskawiczGreg Ikonen · 1 companies · 1 sharedGreg IkonenJUSTIN J. ADAMS · 1 companies · 1 sharedJUSTIN J. ADAMSMARK J. LAMPERT · 1 companies · 1 sharedMARK J. LAMPERTNEIL J. WALLACK · 1 companies · 1 sharedNEIL J. WALLACKNeil Wallack · 1 companies · 1 sharedNeil WallackRichard Crowder · 1 companies · 1 sharedRichard CrowderSTEPHEN J. PADGETTE · 1 companies · 1 sharedSTEPHEN J. PADGET…Mendel Biotechnology Inc · $20.2M raisedMendel Biotechnology …GREGORY J. IKONENGI
GREGORY J. IKONEN Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside GREGORY J. IKONEN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Justin Adams14
Neal Gutterson13
Mark Lampert13
Peter Davis13
Steve Padgette12
MARK J. LAMPERT11
Neil Wallack11
Greg Ikonen11
Richard Crowder11
Brian Staskawicz11
NEIL J. WALLACK11
JUSTIN J. ADAMS11
BRIAN J. STASKAWICZ11
STEPHEN J. PADGETTE11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.